High affinity ligands for the α7 nicotinic receptor that show no cross-reactivity with the 5-HT3 receptor

High affinity ligands for the α7 nicotinic receptor that show no cross-reactivity with the 5-HT3 receptor Discovery and Development of α7 Nicotinic Acetylcholine Receptor Modulators 2-(Arylmethyl)-3-substituted quinuclidines as selective α7 nicotinic receptor ligands Novel, Potent, and Selective Quinoxaline-Based 5-HT₃Receptor Ligands. 1. Further Structure−Activity Relationships and Pharmacological Characterization The 5-HT 3 antagonist tropisetron (ICS 205-930) is a potent and selective α7 nicotinic receptor partial agonist Design, Synthesis, and Preliminary Pharmacological Evaluation of New Quinoline Derivatives as Nicotinic Ligands Novel Potent and Selective Central 5-HT₃ Receptor Ligands Provided with Different Intrinsic Efficacy. 1. Mapping the Central 5-HT₃ Receptor Binding Site by Arylpiperazine Derivatives Bis(het)aryl-1,2,3-triazole quinuclidines as α7 nicotinic acetylcholine receptor ligands: Synthesis, structure affinity relationships, agonism activity, [18F]-radiolabeling and PET study in rats Activity of α7-selective agonists at nicotinic and serotonin 5HT3 receptors expressed in Xenopus oocytes Pharmacological Characteristics and Binding Modes of Caracurine V Analogues and Related Compounds at the Neuronal α7 Nicotinic Acetylcholine Receptor